My Company: In the business of diagnostics and telemedicine, stakes are high. (…) Although Biotts, a company established in 2018, is already in possession of the product, the licence-selling process takes time, commitment, and global travel. The company’s flagship product: MTC-Y transdermal carrier is a system for delivering active substances into the body through the skin. Depending on the actual needs, it can take the form of a cream, an ointment or a patch. For sure, selling such technology is not a piece of cake. Finding a company that is interested in using the carrier for a specific drug is just the starting point for proceeding to the Proof of Concept (PoC) arrangements.
For more about Biotts, please check the latest issue of My Company.